The extracellular matrix (ECM) is one of the major structural components of the tumour microenvironment, and it is mainly composed of collagen molecules. During tumorigenesis the ECM undergoes a profound remodelling to sustain cancer cell aggressiveness. Nevertheless, the molecular mechanisms that orchestrate the ECM remodelling are largely unclear. Recent evidence suggests the existence of a link between the ECM composition and the metabolic state of cancer cells. Cancer cells rewire glutamine (Gln) metabolism to promote tumour progression and, Gln is a precursor of Proline, one of the most abundant amino acids found in collagens. My laboratory has previously shown that the mitochondrial chaperone TRAP1 is a master regulator of metabolic circuits in cancer cells, and cells lacking TRAP1 show lower collagen VI (col VI) levels. In the framework of my thesis, I investigated whether changes in amino acid metabolism sustain cancer cell tumorigenicity by tuning the ECM composition, and the role played by TRAP1 in this process. To this aim, I perfomed several in vitro tumorigenic assays in cancer cells from an aggressive tumour of the peripheral nerve sheath (MPNST). I found that: i) Gln availability influences MPNST proliferation; ii) both TRAP1 and Col VI affect MPNST cell migration and invasion.

The extracellular matrix (ECM) is one of the major structural components of the tumour microenvironment, and it is mainly composed of collagen molecules. During tumorigenesis the ECM undergoes a profound remodelling to sustain cancer cell aggressiveness. Nevertheless, the molecular mechanisms that orchestrate the ECM remodelling are largely unclear. Recent evidence suggests the existence of a link between the ECM composition and the metabolic state of cancer cells. Cancer cells rewire glutamine (Gln) metabolism to promote tumour progression and, Gln is a precursor of Proline, one of the most abundant amino acids found in collagens. My laboratory has previously shown that the mitochondrial chaperone TRAP1 is a master regulator of metabolic circuits in cancer cells, and cells lacking TRAP1 show lower collagen VI (col VI) levels. In the framework of my thesis, I investigated whether changes in amino acid metabolism sustain cancer cell tumorigenicity by tuning the ECM composition, and the role played by TRAP1 in this process. To this aim, I perfomed several in vitro tumorigenic assays in cancer cells from an aggressive tumour of the peripheral nerve sheath (MPNST). I found that: i) Gln availability influences MPNST proliferation; ii) both TRAP1 and Col VI affect MPNST cell migration and invasion.

Investigating the interplay between extracellular matrix and metabolic rewiring in sarcoma aggressiveness

SBUELZ, FRANCESCA
2023/2024

Abstract

The extracellular matrix (ECM) is one of the major structural components of the tumour microenvironment, and it is mainly composed of collagen molecules. During tumorigenesis the ECM undergoes a profound remodelling to sustain cancer cell aggressiveness. Nevertheless, the molecular mechanisms that orchestrate the ECM remodelling are largely unclear. Recent evidence suggests the existence of a link between the ECM composition and the metabolic state of cancer cells. Cancer cells rewire glutamine (Gln) metabolism to promote tumour progression and, Gln is a precursor of Proline, one of the most abundant amino acids found in collagens. My laboratory has previously shown that the mitochondrial chaperone TRAP1 is a master regulator of metabolic circuits in cancer cells, and cells lacking TRAP1 show lower collagen VI (col VI) levels. In the framework of my thesis, I investigated whether changes in amino acid metabolism sustain cancer cell tumorigenicity by tuning the ECM composition, and the role played by TRAP1 in this process. To this aim, I perfomed several in vitro tumorigenic assays in cancer cells from an aggressive tumour of the peripheral nerve sheath (MPNST). I found that: i) Gln availability influences MPNST proliferation; ii) both TRAP1 and Col VI affect MPNST cell migration and invasion.
2023
Investigating the interplay between extracellular matrix and metabolic rewiring in sarcoma aggressiveness
The extracellular matrix (ECM) is one of the major structural components of the tumour microenvironment, and it is mainly composed of collagen molecules. During tumorigenesis the ECM undergoes a profound remodelling to sustain cancer cell aggressiveness. Nevertheless, the molecular mechanisms that orchestrate the ECM remodelling are largely unclear. Recent evidence suggests the existence of a link between the ECM composition and the metabolic state of cancer cells. Cancer cells rewire glutamine (Gln) metabolism to promote tumour progression and, Gln is a precursor of Proline, one of the most abundant amino acids found in collagens. My laboratory has previously shown that the mitochondrial chaperone TRAP1 is a master regulator of metabolic circuits in cancer cells, and cells lacking TRAP1 show lower collagen VI (col VI) levels. In the framework of my thesis, I investigated whether changes in amino acid metabolism sustain cancer cell tumorigenicity by tuning the ECM composition, and the role played by TRAP1 in this process. To this aim, I perfomed several in vitro tumorigenic assays in cancer cells from an aggressive tumour of the peripheral nerve sheath (MPNST). I found that: i) Gln availability influences MPNST proliferation; ii) both TRAP1 and Col VI affect MPNST cell migration and invasion.
Extracellular matrix
Cancer metabolism
TRAP1
Collagen
Sarcoma
File in questo prodotto:
File Dimensione Formato  
Sbuelz_Francesca.pdf

accesso aperto

Dimensione 2.62 MB
Formato Adobe PDF
2.62 MB Adobe PDF Visualizza/Apri

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/79740